Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson's Disease "Off" Episodes

Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson's Disease "Off" Episodes

Parkinson's Disease (PD) is a common neurodegenerative disorder and the leading cause of disability. It causes significant morbidity and disability through a plethora of symptoms, including movement disorders, sleep disturbances, and cognitive and psychiatric symptoms. The traditional pathogene...

Full description

Saved in:
Bibliographic Details
Main Authors: Amnon A. Berger, Ariel Winnick, Jonathan Izygon, Binil M. Jacob, Jessica S. Kaye, Rachel J. Kaye, Elisa E. Neuchat, Adam M. Kaye, Edward S. Alpaugh, Elyse M. Cornett, Andrew H. Han, Alan D. Kaye
Format: Article
Language:English
Published: Open Medical Publishing 2022-06-01
Series:Health Psychology Research
Online Access:https://doi.org/10.52965/001c.36074
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.52965/001c.36074

Similar Items